company background image
0C0 logo

MustGrow Biologics DB:0C0 Stock Report

Last Price

€0.79

Market Cap

€41.9m

7D

-4.4%

1Y

-9.0%

Updated

25 Dec, 2024

Data

Company Financials +

0C0 Stock Overview

An agricultural biotechnology company, focuses on development and commercialization of natural biological technologies and products from mustard seeds. More details

0C0 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health6/6
Dividends0/6

My Notes

Capture your thoughts, links and company narrative

MustGrow Biologics Corp. Competitors

Price History & Performance

Summary of share price highs, lows and changes for MustGrow Biologics
Historical stock prices
Current Share PriceCA$0.79
52 Week HighCA$1.53
52 Week LowCA$0.41
Beta1.32
1 Month Change-34.88%
3 Month Change12.89%
1 Year Change-9.01%
3 Year Change-70.04%
5 Year Change115.30%
Change since IPO301.84%

Recent News & Updates

Recent updates

Shareholder Returns

0C0DE ChemicalsDE Market
7D-4.4%-2.4%-2.0%
1Y-9.0%-8.9%6.8%

Return vs Industry: 0C0 matched the German Chemicals industry which returned -8.9% over the past year.

Return vs Market: 0C0 underperformed the German Market which returned 6.8% over the past year.

Price Volatility

Is 0C0's price volatile compared to industry and market?
0C0 volatility
0C0 Average Weekly Movement15.3%
Chemicals Industry Average Movement3.9%
Market Average Movement4.9%
10% most volatile stocks in DE Market11.4%
10% least volatile stocks in DE Market2.4%

Stable Share Price: 0C0's share price has been volatile over the past 3 months compared to the German market.

Volatility Over Time: 0C0's weekly volatility (15%) has been stable over the past year, but is still higher than 75% of German stocks.

About the Company

FoundedEmployeesCEOWebsite
2014n/aCorey Giassonmustgrow.ca

MustGrow Biologics Corp., an agricultural biotechnology company, focuses on development and commercialization of natural biological technologies and products from mustard seeds. It provides Biocontrol technology platform to treat soil-borne diseases and pests for various crops, including fruit, vegetables, and others; treat unwanted plant growth for use in organic agriculture, and home and garden markets, as well as agriculture markets where glyphosate has been banned; and suppress sprouting, and treat disease and pathogen for storage and food preservation markets. The company also offers TerraMG, a mustard-derived soil biopesticide technology.

MustGrow Biologics Corp. Fundamentals Summary

How do MustGrow Biologics's earnings and revenue compare to its market cap?
0C0 fundamental statistics
Market cap€41.88m
Earnings (TTM)-€164.23k
Revenue (TTM)€3.35m

12.5x

P/S Ratio

-255.0x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
0C0 income statement (TTM)
RevenueCA$4.99m
Cost of RevenueCA$255.69k
Gross ProfitCA$4.74m
Other ExpensesCA$4.98m
Earnings-CA$245.03k

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-0.0047
Gross Margin94.88%
Net Profit Margin-4.91%
Debt/Equity Ratio15.4%

How did 0C0 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/25 03:09
End of Day Share Price 2024/12/23 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

MustGrow Biologics Corp. is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Joseph GomesNOBLE Capital Markets, Inc.